These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 9631473)

  • 21. Urocortin 1 reduces food intake and ghrelin secretion via CRF(2) receptors.
    Yakabi K; Noguchi M; Ohno S; Ro S; Onouchi T; Ochiai M; Takabayashi H; Takayama K; Harada Y; Sadakane C; Hattori T
    Am J Physiol Endocrinol Metab; 2011 Jul; 301(1):E72-82. PubMed ID: 21540451
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Participation of corticotropin-releasing factor type 2 receptors in the acute, chronic and withdrawal actions of nicotine associated with feeding behavior in rats.
    Kamdi SP; Nakhate KT; Dandekar MP; Kokare DM; Subhedar NK
    Appetite; 2009 Dec; 53(3):354-62. PubMed ID: 19635511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic cocaine administration switches corticotropin-releasing factor2 receptor-mediated depression to facilitation of glutamatergic transmission in the lateral septum.
    Liu J; Yu B; Orozco-Cabal L; Grigoriadis DE; Rivier J; Vale WW; Shinnick-Gallagher P; Gallagher JP
    J Neurosci; 2005 Jan; 25(3):577-83. PubMed ID: 15659593
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Corticotropin releasing factor receptor 1 (CRF1) and CRF2 agonists exert an anti-inflammatory effect during the early phase of inflammation suppressing LPS-induced TNF-alpha release from macrophages via induction of COX-2 and PGE2.
    Tsatsanis C; Androulidaki A; Dermitzaki E; Gravanis A; Margioris AN
    J Cell Physiol; 2007 Mar; 210(3):774-83. PubMed ID: 17117478
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Involvement of the corticotropin-releasing factor (CRF) type 2 receptor in CRF-induced thyrotropin release by the amphibian pituitary gland.
    Okada R; Miller MF; Yamamoto K; De Groef B; Denver RJ; Kikuyama S
    Gen Comp Endocrinol; 2007 Feb; 150(3):437-44. PubMed ID: 17188689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential roles of corticotropin-releasing factor receptor subtypes 1 and 2 in opiate withdrawal and in relapse to opiate dependence.
    Lu L; Liu D; Ceng X; Ma L
    Eur J Neurosci; 2000 Dec; 12(12):4398-404. PubMed ID: 11122350
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Central corticotropin-releasing hormone receptors modulate hypothalamic-pituitary-adrenocortical and sympathoadrenal activity during stress.
    Jezova D; Ochedalski T; Glickman M; Kiss A; Aguilera G
    Neuroscience; 1999; 94(3):797-802. PubMed ID: 10579570
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The CRF1 receptor mediates the excitatory actions of corticotropin releasing factor (CRF) in the developing rat brain: in vivo evidence using a novel, selective, non-peptide CRF receptor antagonist.
    Baram TZ; Chalmers DT; Chen C; Koutsoukos Y; De Souza EB
    Brain Res; 1997 Oct; 770(1-2):89-95. PubMed ID: 9372207
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Corticotropin-releasing factor and Urocortin I modulate excitatory glutamatergic synaptic transmission.
    Liu J; Yu B; Neugebauer V; Grigoriadis DE; Rivier J; Vale WW; Shinnick-Gallagher P; Gallagher JP
    J Neurosci; 2004 Apr; 24(16):4020-9. PubMed ID: 15102917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential regulation of CREB and ERK phosphorylation through corticotropin-releasing factor receptors type 1 and 2 in AtT-20 and A7r5 cells.
    Kageyama K; Hanada K; Moriyama T; Imaizumi T; Satoh K; Suda T
    Mol Cell Endocrinol; 2007 Jan; 263(1-2):90-102. PubMed ID: 17027144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Subtype-selective corticotropin-releasing factor receptor agonists exert contrasting, but not opposite, effects on anxiety-related behavior in rats.
    Zhao Y; Valdez GR; Fekete EM; Rivier JE; Vale WW; Rice KC; Weiss F; Zorrilla EP
    J Pharmacol Exp Ther; 2007 Dec; 323(3):846-54. PubMed ID: 17855476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Central administration of urocortin inhibits vasopressin release in conscious rats.
    Kakiya S; Yokoi H; Arima H; Iwasaki Y; Oki Y; Oiso Y
    Neurosci Lett; 1998 May; 248(2):144-6. PubMed ID: 9654364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification and characterization of multiple corticotropin-releasing factor type 2 receptor isoforms in the rat esophagus.
    Wu SV; Yuan PQ; Wang L; Peng YL; Chen CY; Taché Y
    Endocrinology; 2007 Apr; 148(4):1675-87. PubMed ID: 17218420
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urocortins and the regulation of gastrointestinal motor function and visceral pain.
    Martinez V; Wang L; Million M; Rivier J; Taché Y
    Peptides; 2004 Oct; 25(10):1733-44. PubMed ID: 15476940
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of corticotropin-releasing factor on neuronal activity in the serotonergic dorsal raphe nucleus.
    Kirby LG; Rice KC; Valentino RJ
    Neuropsychopharmacology; 2000 Feb; 22(2):148-62. PubMed ID: 10649828
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CRF-1 antagonist and CRF-2 agonist decrease binge-like ethanol drinking in C57BL/6J mice independent of the HPA axis.
    Lowery EG; Spanos M; Navarro M; Lyons AM; Hodge CW; Thiele TE
    Neuropsychopharmacology; 2010 May; 35(6):1241-52. PubMed ID: 20130533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Corticotropin-releasing factor CRF1, but not CRF2, receptors mediate anxiogenic-like behavior.
    Heinrichs SC; Lapsansky J; Lovenberg TW; De Souza EB; Chalmers DT
    Regul Pept; 1997 Jul; 71(1):15-21. PubMed ID: 9299637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intracerebroventricular urocortin 3 counteracts central acyl ghrelin-induced hyperphagic and gastroprokinetic effects via CRF receptor 2 in rats.
    Yeh C; Ting CH; Doong ML; Chi CW; Lee SD; Chen CY
    Drug Des Devel Ther; 2016; 10():3281-3290. PubMed ID: 27757017
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Central CRF inhibits gastric emptying of a nutrient solid meal in rats: the role of CRF2 receptors.
    Martinez V; Barquist E; Rivier J; Taché Y
    Am J Physiol; 1998 May; 274(5):G965-70. PubMed ID: 9612279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiovascular effects of long-term central and peripheral administration of urocortin, corticotropin-releasing factor, and adrenocorticotropin in sheep.
    Weisinger RS; Blair-West JR; Burns P; Denton DA; Purcell B; Vale W; Rivier J; Weisinger HS; May CN
    Endocrinology; 2004 Dec; 145(12):5598-604. PubMed ID: 15319360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.